Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
STAT1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 9.66E4 | Evidence | |||||
STAT1 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 9.66E4 | Evidence | |||||
STAT1 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 9.66E4 | Evidence | |||||
STAT1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 5.32E4 | Evidence | |||||
STAT1 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 5.32E4 | Evidence | |||||
STAT1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 4.56E4 | Evidence | |||||
STAT1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 3.01E4 | Evidence | |||||
STAT1 | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 2.77E4 | Evidence | |||||
STAT1 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 1.82E4 | Evidence | |||||
STAT1 | CRKL | CRKL: Crk-like protein | 1.07E4 | Evidence | |||||
STAT1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 9.88E3 | Evidence | |||||
STAT1 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 6.78E3 | Evidence | |||||
STAT1 | STAT3 | 3.40E3 | Evidence | ||||||
STAT1 | CREBBP | CREBBP, CBP: CREB-binding protein | 3.27E3 | Evidence | |||||
STAT1 | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 2.69E3 | Evidence | |||||
STAT1 | GRAP | GRAP: GRB2-related adapter protein | 1.25E3 | Evidence | |||||
STAT1 | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 1.25E3 | Evidence | |||||
STAT1 | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 224.0 | Evidence | |||||
STAT1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
STAT1 | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 200.0 | Evidence | |||||
STAT1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 200.0 | Evidence | |||||
STAT1 | SHC4 | SHC-transforming protein 4 | 149.0 | Evidence | |||||
STAT1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 135.0 | Evidence | |||||
STAT1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 135.0 | Evidence | |||||
STAT1 | SYK | SYK: Tyrosine-protein kinase SYK | 135.0 | Evidence | |||||
STAT1 | JAK1 | 135.0 | Evidence | ||||||
STAT1 | BMX | N/A | 135.0 | Evidence | |||||
STAT1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 135.0 | Evidence | |||||
STAT1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 135.0 | Evidence | |||||
STAT1 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 135.0 | Evidence | |||||
STAT1 | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 125.0 | Evidence | |||||
STAT1 | LYN | LYN: Tyrosine-protein kinase Lyn | 121.0 | Evidence | |||||
STAT1 | INSR | INSR: Insulin receptor precursor | 110.0 | Evidence | |||||
STAT1 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 110.0 | Evidence | |||||
STAT1 | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 110.0 | Evidence | |||||
STAT1 | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 110.0 | Evidence | |||||
STAT1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 110.0 | Evidence | |||||
STAT1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 110.0 | Evidence | |||||
STAT1 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 110.0 | Evidence | |||||
STAT1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 110.0 | Evidence | |||||
STAT1 | CSK | CSK: Tyrosine-protein kinase CSK | 104.0 | Evidence | |||||
STAT1 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 89.20 | Evidence | |||||
STAT1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 79.90 | Evidence | |||||
STAT1 | HCK | N/A | 79.90 | Evidence | |||||
STAT1 | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 79.90 | Evidence | |||||
STAT1 | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 74.9 | Evidence | |||||
STAT1 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 74.9 | Evidence | |||||
STAT1 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 64.40 | Evidence | |||||
STAT1 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 57.70 | Evidence | |||||
STAT1 | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 49.10 | Evidence | |||||
STAT1 | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 49.10 | Evidence | |||||
STAT1 | MET | MET: Hepatocyte growth factor receptor precursor | 49.10 | Evidence | |||||
STAT1 | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 44.00 | Evidence | |||||
STAT1 | IRS2 | IRS2: Insulin receptor substrate 2 | 37.80 | Evidence | |||||
STAT1 | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 37.80 | Evidence | |||||
STAT1 | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 33.90 | Evidence | |||||
STAT1 | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 33.90 | Evidence | |||||
STAT1 | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 33.90 | Evidence | |||||
STAT1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 33.90 | Evidence | |||||
STAT1 | LOC389305 | Uncharacterized protein ENSP00000349185 (Fragment) | 31.00 | Evidence | |||||
STAT1 | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 24.90 | Evidence | |||||
STAT1 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 24.90 | Evidence | |||||
STAT1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 24.90 | Evidence | |||||
STAT1 | IRS1 | IRS1: Insulin receptor substrate 1 | 22.90 | Evidence | |||||
STAT1 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 22.90 | Evidence | |||||
STAT1 | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 22.90 | Evidence | |||||
STAT1 | ETS2 | ETS2: Protein C-ets-2 | 22.90 | Evidence | |||||
STAT1 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 22.30 | Evidence | |||||
STAT1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 22.30 | Evidence | |||||
STAT1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 22.30 | Evidence | |||||
STAT1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 22.30 | Evidence | |||||
STAT1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 22.30 | Evidence | |||||
STAT1 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 22.30 | Evidence | |||||
STAT1 | APS | SH2B2, APS: SH2B adapter protein 2 | 22.30 | Evidence | |||||
STAT1 | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 22.30 | Evidence | |||||
STAT1 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 22.30 | Evidence | |||||
STAT1 | MYO3A | MYO3A: Myosin IIIA | 20.50 | Evidence | |||||
STAT1 | DYRK3 | N/A | 20.50 | Evidence | |||||
STAT1 | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 20.50 | Evidence | |||||
STAT1 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 20.50 | Evidence | |||||
STAT1 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 20.50 | Evidence | |||||
STAT1 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 20.50 | Evidence | |||||
STAT1 | PIK3CD | PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i | 19.70 | Evidence | |||||
STAT1 | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 19.70 | Evidence | |||||
STAT1 | IRF3 | IRF3: Interferon regulatory factor 3 | 19.70 | Evidence | |||||
STAT1 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 19.70 | Evidence | |||||
STAT1 | TP73 | TP73, P73: Tumor protein p73 | 19.70 | Evidence | |||||
STAT1 | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 19.50 | Evidence | |||||
STAT1 | H1FX | H1FX: Histone H1x | 19.10 | Evidence | |||||
STAT1 | SAFB | SAFB, HAP, HET, SAFB1: Scaffold attachment factor B | 19.10 | Evidence | |||||
STAT1 | EP300 | N/A | 18.90 | Evidence | |||||
STAT1 | EWSR1 | EWSR1, EWS: RNA-binding protein EWS | 18.60 | Evidence | |||||
STAT1 | PPP2CB | PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | 18.30 | Evidence | |||||
STAT1 | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 17.60 | Evidence | |||||
STAT1 | DAB2 | DAB2, DOC2: Disabled homolog 2 | 17.60 | Evidence | |||||
STAT1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 17.60 | Evidence | |||||
STAT1 | SSH1 | SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 | 17.60 | Evidence | |||||
STAT1 | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 17.60 | Evidence | |||||
STAT1 | CDK2 | CDK2: Cell division protein kinase 2 | 17.60 | Evidence | |||||
STAT1 | CDK5 | CDK5: Cell division protein kinase 5 | 17.60 | Evidence | |||||
STAT1 | FOSL2 | FOSL2, FRA2: Fos-related antigen 2 | 17.10 | Evidence | |||||
STAT1 | JUNB | JUNB: Transcription factor jun-B | 17.10 | Evidence | |||||
STAT1 | FOS | FOS, G0S7: Proto-oncogene protein c-fos | 17.10 | Evidence | |||||
STAT1 | HES1 | HES1, HL, HRY: Transcription factor HES-1 | 17.10 | Evidence | |||||
STAT1 | JUN | JUN: Transcription factor AP-1 | 17.10 | Evidence | |||||
STAT1 | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 17.10 | Evidence | |||||
STAT1 | TP53 | TP53, P53: Cellular tumor antigen p53 | 17.00 | Evidence | |||||
STAT1 | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 16.70 | Evidence | |||||
STAT1 | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 15.70 | Evidence | |||||
STAT1 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 15.70 | Evidence | |||||
STAT1 | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 15.70 | Evidence | |||||
STAT1 | CCR5 | CCR5: CCR5 receptor (Fragment) | 15.70 | Evidence | |||||
STAT1 | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 15.70 | Evidence | |||||
STAT1 | EPOR | EPOR: Erythropoietin receptor precursor | 15.70 | Evidence | |||||
STAT1 | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 15.70 | Evidence | |||||
STAT1 | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 15.70 | Evidence | |||||
STAT1 | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 15.70 | Evidence | |||||
STAT1 | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 15.70 | Evidence | |||||
STAT1 | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 15.70 | Evidence | |||||
STAT1 | PRLR | PRLR: Prolactin receptor precursor | 15.70 | Evidence | |||||
STAT1 | GHR | GHR: Growth hormone receptor precursor | 15.70 | Evidence | |||||
STAT1 | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 15.70 | Evidence | |||||
STAT1 | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 15.70 | Evidence | |||||
STAT1 | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 15.70 | Evidence | |||||
STAT1 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 15.70 | Evidence | |||||
STAT1 | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 15.10 | Evidence | |||||
STAT1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 15.10 | Evidence | |||||
STAT1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 15.00 | Evidence | |||||
STAT1 | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 15.00 | Evidence | |||||
STAT1 | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 15.00 | Evidence | |||||
STAT1 | RIPK1 | RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 | 15.00 | Evidence | |||||
STAT1 | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 14.10 | Evidence | |||||
STAT1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 13.50 | Evidence | |||||
STAT1 | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 13.40 | Evidence | |||||
STAT1 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 13.40 | Evidence | |||||
STAT1 | PAK7 | PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 | 13.40 | Evidence | |||||
STAT1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 13.40 | Evidence | |||||
STAT1 | CDC2 | CDC2: Cell division control protein 2 homolog | 13.40 | Evidence | |||||
STAT1 | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 13.40 | Evidence | |||||
STAT1 | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 13.40 | Evidence | |||||
STAT1 | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 13.40 | Evidence | |||||
STAT1 | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 11.70 | Evidence | |||||
STAT1 | GRB10 | N/A | 11.70 | Evidence | |||||
STAT1 | BIN1 | BIN1, AMPHL: Myc box-dependent-interacting protein 1 | 11.60 | Evidence | |||||
STAT1 | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 11.50 | Evidence | |||||
STAT1 | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 11.50 | Evidence | |||||
STAT1 | INSRR | INSRR, IRR: Insulin receptor-related protein precursor | 11.40 | Evidence | |||||
STAT1 | MCM2 | MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 | 10.70 | Evidence | |||||
STAT1 | MCM4 | MCM4, CDC21: DNA replication licensing factor MCM4 | 10.70 | Evidence | |||||
STAT1 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 10.30 | Evidence | |||||
STAT1 | CREB1 | CREB1: cAMP response element-binding protein | 10.30 | Evidence | |||||
STAT1 | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 10.30 | Evidence | |||||
STAT1 | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 10.30 | Evidence | |||||
STAT1 | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 10.00 | Evidence | |||||
STAT1 | E2F1 | E2F1, RBBP3: Transcription factor E2F1 | 9.96 | Evidence | |||||
STAT1 | NFATC2 | NFATC2, NFAT1, NFATP: Nuclear factor of activated T-cells, cytoplasmic 2 | 9.96 | Evidence | |||||
STAT1 | HDAC3 | HDAC3: Histone deacetylase 3 | 9.96 | Evidence | |||||
STAT1 | GRLF1 | N/A | 9.96 | Evidence | |||||
STAT1 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 9.92 | Evidence | |||||
STAT1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 9.92 | Evidence | |||||
STAT1 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 9.92 | Evidence | |||||
STAT1 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 9.92 | Evidence | |||||
STAT1 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 9.92 | Evidence | |||||
STAT1 | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 9.55 | Evidence | |||||
STAT1 | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 9.55 | Evidence | |||||
STAT1 | MDGA1 | MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein | 9.55 | Evidence | |||||
STAT1 | ANXA6 | ANXA6, ANX6: Annexin A6 | 9.55 | Evidence | |||||
STAT1 | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 9.55 | Evidence | |||||
STAT1 | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.55 | Evidence | |||||
STAT1 | FOXO1A | FOXO1A, FKHR: Forkhead box protein O1A | 8.92 | Evidence | |||||
STAT1 | HDAC1 | HDAC1, RPD3L1: Histone deacetylase 1 | 8.92 | Evidence | |||||
STAT1 | RELA | RELA, NFKB3: Transcription factor p65 | 8.92 | Evidence | |||||
STAT1 | NFE2L2 | NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 | 8.92 | Evidence | |||||
STAT1 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 8.92 | Evidence | |||||
STAT1 | GCN5L2 | GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 | 8.92 | Evidence | |||||
STAT1 | MAFG | MAFG: Transcription factor MafG | 8.92 | Evidence | |||||
STAT1 | PCAF | PCAF: Histone acetyltransferase PCAF | 8.92 | Evidence | |||||
STAT1 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 8.92 | Evidence | |||||
STAT1 | MLL | MLL, ALL1, HRX, HTRX, TRX1: Zinc finger protein HRX | 8.92 | Evidence | |||||
STAT1 | ATF1 | ATF1: Cyclic AMP-dependent transcription factor ATF-1 | 8.92 | Evidence | |||||
STAT1 | FLNB | FLNB, FLN1L, FLN3, TABP, TAP: Filamin-B | 8.89 | Evidence | |||||
STAT1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 8.89 | Evidence | |||||
STAT1 | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 8.55 | Evidence | |||||
STAT1 | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 8.55 | Evidence | |||||
STAT1 | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 8.55 | Evidence | |||||
STAT1 | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 8.22 | Evidence | |||||
STAT1 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 8.22 | Evidence | |||||
STAT1 | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 8.20 | Evidence | |||||
STAT1 | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 8.20 | Evidence | |||||
STAT1 | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 7.72 | Evidence | |||||
STAT1 | MAL2 | MAL2: Protein MAL2 | 7.72 | Evidence | |||||
STAT1 | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 7.72 | Evidence | |||||
STAT1 | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 7.36 | Evidence | |||||
STAT1 | THBS3 | THBS3, TSP3: Thrombospondin-3 precursor | 7.36 | Evidence | |||||
STAT1 | TERF2IP | TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 | 7.26 | Evidence | |||||
STAT1 | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 7.26 | Evidence | |||||
STAT1 | ESRRA | ESRRA, ERR1, ESRL1, NR3B1: Steroid hormone receptor ERR1 | 7.26 | Evidence | |||||
STAT1 | LOC649805 | Ig heavy chain V-II region COR | 7.14 | Evidence | |||||
STAT1 | NULL | Ig lambda chain V-II region NEI | 7.14 | Evidence | |||||
STAT1 | EVL | EVL, RNB6: Ena/VASP-like protein | 7.14 | Evidence | |||||
STAT1 | CRK | CRK: Proto-oncogene C-crk | 7.14 | Evidence | |||||
STAT1 | TSHR | N/A | 6.92 | Evidence | |||||
STAT1 | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 6.83 | Evidence | |||||
STAT1 | CRIP2 | CRIP2, CRP2: Cysteine-rich protein 2 | 6.82 | Evidence | |||||
STAT1 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 6.82 | Evidence | |||||
STAT1 | HDAC2 | HDAC2: Histone deacetylase 2 | 6.80 | Evidence | |||||
STAT1 | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 6.80 | Evidence | |||||
STAT1 | BARD1 | BARD1: BRCA1-associated RING domain protein 1 | 6.50 | Evidence | |||||
STAT1 | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 6.40 | Evidence | |||||
STAT1 | SYNGAP1 | SYNGAP1, KIAA1938: Ras GTPase-activating protein SynGAP | 6.39 | Evidence | |||||
STAT1 | IL6R | IL6R: Interleukin-6 receptor alpha chain precursor | 6.26 | Evidence | |||||
STAT1 | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 6.26 | Evidence | |||||
STAT1 | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 6.26 | Evidence | |||||
STAT1 | EIF5AP1 | EIF5A: Eukaryotic translation initiation factor 5A-1 | 6.24 | Evidence | |||||
STAT1 | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 6.24 | Evidence | |||||
STAT1 | MARK2 | N/A | 6.14 | Evidence | |||||
STAT1 | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 6.11 | Evidence | |||||
STAT1 | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 6.11 | Evidence | |||||
STAT1 | TRIM39 | TRIM39, RNF23, TFP: Tripartite motif-containing protein 39 | 5.87 | Evidence | |||||
STAT1 | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 5.73 | Evidence | |||||
STAT1 | KLF13 | KLF13, BTEB3, NSLP1: Krueppel-like factor 13 | 5.73 | Evidence | |||||
STAT1 | BUB3 | BUB3: Mitotic checkpoint protein BUB3 | 5.73 | Evidence | |||||
STAT1 | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 5.73 | Evidence | |||||
STAT1 | TNC | TNC, HXB: Tenascin precursor | 5.61 | Evidence | |||||
STAT1 | VDR | VDR, NR1I1: Vitamin D3 receptor | 5.59 | Evidence | |||||
STAT1 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence | |||||
STAT1 | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 4.80 | Evidence | |||||
STAT1 | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 4.80 | Evidence | |||||
STAT1 | NCF2 | NCF2: Neutrophil cytosol factor 2 | 4.80 | Evidence | |||||
STAT1 | NMI | NMI: N-myc-interactor | 4.80 | Evidence | |||||
STAT1 | OSTF1 | N/A | 4.80 | Evidence | |||||
STAT1 | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 4.49 | Evidence | |||||
STAT1 | S100A9 | S100A9, CAGB, CFAG, MRP14: Protein S100-A9 | 4.48 | Evidence | |||||
STAT1 | ABCF1 | N/A | 3.88 | Evidence | |||||
STAT1 | VCPIP1 | VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 | 3.88 | Evidence | |||||
STAT1 | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 3.88 | Evidence | |||||
STAT1 | POU2F1 | POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 | 3.88 | Evidence | |||||
STAT1 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 3.88 | Evidence | |||||
STAT1 | CHUK | N/A | 3.88 | Evidence | |||||
STAT1 | SRA1 | APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 | 3.70 | Evidence | |||||
STAT1 | ASB6 | ASB6: Ankyrin repeat and SOCS box protein 6 | 3.70 | Evidence | |||||
STAT1 | TRHR | TRHR: Thyrotropin-releasing hormone receptor | 3.61 | Evidence | |||||
STAT1 | HNRPM | HNRPM, NAGR1: Heterogeneous nuclear ribonucleoprotein M | 3.47 | Evidence | |||||
STAT1 | POLR2A | POLR2A: Uncharacterized protein POLR2A | 3.47 | Evidence | |||||
STAT1 | NUP98 | N/A | 3.47 | Evidence | |||||
STAT1 | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 3.47 | Evidence | |||||
STAT1 | COPA | COPA: Coatomer subunit alpha | 3.47 | Evidence | |||||
STAT1 | UNG | N/A | 3.47 | Evidence | |||||
STAT1 | PAPOLA | PAPOLA, PAP: Poly(A) polymerase alpha | 3.47 | Evidence | |||||
STAT1 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 3.47 | Evidence | |||||
STAT1 | JDP2 | jdp2, JDP2: Jun dimerization protein 2 | 3.34 | Evidence | |||||
STAT1 | MYBL2 | MYBL2, BMYB: Myb-related protein B | 3.34 | Evidence | |||||
STAT1 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 3.34 | Evidence | |||||
STAT1 | TMEM1 | TMEM1, EHOC1: Transmembrane protein 1 | 3.34 | Evidence | |||||
STAT1 | C20orf18 | N/A | 3.34 | Evidence | |||||
STAT1 | TDG | TDG: G/T mismatch-specific thymine DNA glycosylase | 3.34 | Evidence | |||||
STAT1 | IRF7 | N/A | 3.34 | Evidence | |||||
STAT1 | PTMA | N/A | 3.34 | Evidence | |||||
STAT1 | DAXX | DAXX, BING2, DAP6: Death domain-associated protein 6 | 3.34 | Evidence | |||||
STAT1 | SREBF2 | N/A | 3.34 | Evidence | |||||
STAT1 | AR | AR, DHTR, NR3C4: Androgen receptor | 3.34 | Evidence | |||||
STAT1 | IKBKG | IKBKG, FIP3, NEMO: NF-kappa-B essential modulator | 3.34 | Evidence | |||||
STAT1 | SRF | SRF: Serum response factor | 3.34 | Evidence | |||||
STAT1 | ATR | ATR, FRP1: Serine/threonine-protein kinase ATR | 3.34 | Evidence | |||||
STAT1 | MSL3L1 | MSL3L1: Male-specific lethal 3-like 1 | 3.34 | Evidence | |||||
STAT1 | MYB | MYB: Myb proto-oncogene protein | 3.34 | Evidence | |||||
STAT1 | NCOA3 | N/A | 3.34 | Evidence | |||||
STAT1 | CDX2 | CDX2, CDX3: Homeobox protein CDX-2 | 3.34 | Evidence | |||||
STAT1 | CUTL1 | CUTL1: Homeobox protein cut-like 1 | 3.34 | Evidence | |||||
STAT1 | BUB1 | 3.31 | Evidence | ||||||
STAT1 | VIL1 | VIL1, VIL: Villin-1 | 3.28 | Evidence | |||||
STAT1 | STAP2 | Uncharacterized protein ENSP00000317912 | 3.28 | Evidence | |||||
STAT1 | BCR | N/A | 3.28 | Evidence | |||||
STAT1 | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 3.28 | Evidence | |||||
STAT1 | GABPA | GABPA, E4TF1A: GA-binding protein alpha chain | 3.18 | Evidence | |||||
STAT1 | EDNRB | EDNRB, ETRB: Endothelin B receptor precursor | 3.07 | Evidence | |||||
STAT1 | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 2.99 | Evidence | |||||
STAT1 | COPE | COPE: Coatomer subunit epsilon | 2.99 | Evidence | |||||
STAT1 | MSH6 | MSH6, GTBP: DNA mismatch repair protein MSH6 | 2.99 | Evidence | |||||
STAT1 | H3F3A | H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 | 2.99 | Evidence | |||||
STAT1 | DDX5 | DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 | 2.99 | Evidence | |||||
STAT1 | TRERF1 | TRERF1, BCAR2, RAPA, TREP132: Transcriptional-regulating factor 1 | 2.99 | Evidence | |||||
STAT1 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.99 | Evidence | |||||
STAT1 | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 2.99 | Evidence | |||||
STAT1 | HTATIP | N/A | 2.99 | Evidence | |||||
STAT1 | SMAD4 | SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 | 2.99 | Evidence | |||||
STAT1 | POLB | POLB: DNA polymerase beta | 2.99 | Evidence | |||||
STAT1 | ZNF76 | ZNF76, D6S229E: Zinc finger protein 76 | 2.99 | Evidence | |||||
STAT1 | KLF5 | KLF5, BTEB2, CKLF, IKLF: Krueppel-like factor 5 | 2.99 | Evidence | |||||
STAT1 | AKAP8 | AKAP8, AKAP95: A-kinase anchor protein 8 | 2.99 | Evidence | |||||
STAT1 | HOXB6 | HOXB6, HOX2B: Homeobox protein Hox-B6 | 2.99 | Evidence | |||||
STAT1 | HOXA10 | HOXA10, HOX1H: Homeobox protein Hox-A10 | 2.99 | Evidence | |||||
STAT1 | SPEN | SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein | 2.99 | Evidence | |||||
STAT1 | EGR1 | EGR1, ZNF225: Early growth response protein 1 | 2.99 | Evidence | |||||
STAT1 | RBBP4 | RBBP4, RBAP48: Histone-binding protein RBBP4 | 2.99 | Evidence | |||||
STAT1 | SMAD3 | SMAD3, MADH3: Mothers against decapentaplegic homolog 3 | 2.99 | Evidence | |||||
STAT1 | EEA1 | EEA1, ZFYVE2: Early endosome antigen 1 | 2.99 | Evidence | |||||
STAT1 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 2.99 | Evidence | |||||
STAT1 | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 2.93 | Evidence | |||||
STAT1 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 2.93 | Evidence | |||||
STAT1 | PTPN11 | N/A | 2.93 | Evidence | |||||
STAT1 | VCP | VCP: Transitional endoplasmic reticulum ATPase | 2.93 | Evidence | |||||
STAT1 | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 2.93 | Evidence | |||||
STAT1 | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 2.91 | Evidence | |||||
STAT1 | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 2.91 | Evidence | |||||
STAT1 | IL3RA | IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor | 2.71 | Evidence | |||||
STAT1 | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 2.71 | Evidence | |||||
STAT1 | SUPT5H | SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 | 2.63 | Evidence | |||||
STAT1 | RASA4 | RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 | 2.60 | Evidence |